Form 8-K

 

 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

Date of Report: July 22, 2008

(Date of earliest event reported)

INTUITIVE SURGICAL, INC.

(exact name of registrant as specified in its charter)

 

Delaware   000-30713   77-0416458

(State or other jurisdiction

of incorporation or

organization)

  Commission File Number   (I.R.S. Employer Identification No.)

1266 Kifer Road

Sunnyvale, California 94086

(Address of Principal executive offices, including zip code)

(408) 523-2100

(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 2.02. Results of Operations and Financial Condition.

On July 22, 2008, Intuitive Surgical, Inc. (“Intuitive”) issued a press release announcing its financial results for the quarter ended June 30, 2008. A copy of the press release is attached hereto as Exhibit 99.1.

The information in this Current Report, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities under that Section and shall not be deemed to be incorporated by reference into any filing of Intuitive under the Securities Act of 1933 or the Exchange Act.

 

Item 9.01. Financial Statements and Exhibits.

d) Exhibits.

The following exhibit is furnished with this report on Form 8-K:

 

99.1    Press release issued by Intuitive Surgical, July 22, 2008.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    INTUITIVE SURGICAL, INC.
Date: July 22, 2008     By   /s/ Marshall L. Mohr
      Name:   Marshall L. Mohr
      Title:  

Senior Vice President and

Chief Financial Officer


EXHIBIT INDEX

 

Exhibit No.

  

Description

99.1    Press Release issued by Intuitive Surgical, July 22, 2008
Press Release

Exhibit 99.1

 

FOR IMMEDIATE RELEASE    Contacts:    Ben Gong    408-523-2175
      Rae Covington    408-523-2161

INTUITIVE SURGICAL ANNOUNCES $219.2 MILLION SECOND QUARTER REVENUE, UP 56%

SUNNYVALE, CALIF. July 22, 2008 – Intuitive Surgical, Inc. (NASDAQ: ISRG), the industry leader in surgical robotics, today reported second quarter 2008 revenue of $219.2 million, increasing 56% from $140.2 million for the second quarter of 2007. Second quarter 2008 revenue growth was driven by continued robotic procedure adoption and higher da Vinci ® Surgical System sales.

Second quarter 2008 instruments and accessories revenue increased 61% to $73.6 million from $45.8 million during the second quarter of 2007. Second quarter 2008 da Vinci ® Surgical Systems revenue increased 57% to $116.2 million from $74.1 million during the second quarter of 2007. Second quarter 2008 service and training revenue increased 44% to $29.4 million from $20.3 million during the second quarter of 2007.

 

     Three Months Ended
June 30,
   Six Months Ended
June 30,

Revenue ($Millions)

   2008    2007    Increase    2008    2007    Increase

Instruments/Accessories

   $ 73.6    $ 45.8    $ 27.8    $ 135.5    $ 86.1    $ 49.4

Systems

     116.2      74.1      42.1      215.3      130.3      85.0

Service/Training

     29.4      20.3      9.1      56.6      38.1      18.5
                                         
   $ 219.2    $ 140.2    $ 79.0    $ 407.4    $ 254.5    $ 152.9
                                         

Second quarter 2008 operating income increased 74% to $78.2 million, compared with $45.0 million for the second quarter of 2007. Operating results for the second quarter of 2008 included $19.7 million of non-cash stock-based compensation expense in accordance with the Financial Accounting Standards Board SFAS 123R, compared with $9.4 million for the second quarter of 2007.

Second quarter 2008 net income increased 67% to $51.2 million, compared with $30.7 million for the second quarter of 2007. Diluted earnings per share increased to $1.28 for the second quarter of 2008 from $0.79 for the second quarter of 2007.


Intuitive ended the second quarter of 2008 with cash, cash equivalents and investments of $740 million, up $104 million from December 31, 2007.

Commenting on the announcement, Lonnie Smith, Chairman and CEO of Intuitive Surgical, said, “We are pleased with our second quarter revenue and earnings growth. These results reflect the continued adoption of the da Vinci Surgical System platform across a broadening group of surgical procedures.”

The Company will also announce these results at a conference call today at 1:30 pm PDT. The dial-in numbers for the call are 877-909-3508 for participants located in the U.S. and 517-645-6051 for participants located outside the U.S. The passcode is ISRG and the meeting leader is Mr. Lonnie Smith. To access financial information that will be discussed on the call, please visit Intuitive Surgical’s website at www.intuitivesurgical.com.

About Intuitive’s Products:

The da Vinci® Surgical System consists of a surgeon’s viewing and control console having an integrated, high-performance InSite® 3-D, high definition vision system, a patient-side cart consisting of three or four robotic arms that position and precisely maneuver endoscopic instruments and an endoscope, and a variety of articulating EndoWrist® Instruments. By integrating computer-enhanced technology with surgeons’ technical skills, Intuitive believes that its system enables surgeons to perform better surgery in a manner never before experienced. The da Vinci® Surgical System seamlessly and directly translates the surgeon’s natural hand, wrist and finger movements on instrument controls at the surgeon’s console outside the patient’s body into corresponding micro-movements of the instrument tips positioned inside the patient through small puncture incisions, or ports.

Intuitive®, da Vinci®, da Vinci® S™, InSite®, and EndoWrist® are trademarks or registered trademarks of Intuitive Surgical, Inc.

# # #


This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are necessarily estimates reflecting the best judgment of our management and involve a number of risks and uncertainties that could cause actual results to differ materially from those suggested by the forward-looking statements. These forward-looking statements should, therefore, be considered in light of various important factors, including the following: timing and success of product development and market acceptance of developed products; regulatory approvals, clearances and restrictions; guidelines and recommendations in the health care and patient communities; intellectual property positions and litigation; competition in the medical device industry and in the specific markets of surgery in which Intuitive Surgical operates; and unanticipated manufacturing disruptions; delays in regulatory approvals of new manufacturing facilities or the inability to meet demand for products. Words such as “estimate”, “project”, “plan”, “intend”, “expect”, “anticipate”, “believe” and similar expressions are intended to identify forward-looking statements. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. We undertake no obligation to publicly update or release any revisions to these forward-looking statements to reflect events or circumstances after the date of this press release or to reflect the occurrence of unanticipated events.


INTUITIVE SURGICAL, INC.

UNAUDITED CONSOLIDATED STATEMENTS OF INCOME

(IN THOUSANDS, EXCEPT PER SHARE DATA)

 

     Three Months Ended
June 30,
   Six Months Ended
June 30,
     2008    2007    2008    2007

Revenue:

           

Products

   $ 189,780    $ 119,885    $ 350,731    $ 216,334

Services

     29,409      20,364      56,652      38,144
                           

Total revenue

     219,189      140,249      407,383      254,478

Cost of revenue:

           

Products

     50,036      35,656      94,888      64,762

Services

     13,097      10,485      26,632      19,100
                           

Total cost of revenue *

     63,133      46,141      121,520      83,862

Gross profit

     156,056      94,108      285,863      170,616

Operating expenses:

           

Selling, general and administrative

     57,504      38,883      106,138      72,828

Research and development

     20,357      10,192      36,658      18,416
                           

Total operating expenses *

     77,861      49,075      142,796      91,244

Income from operations

     78,195      45,033      143,067      79,372

Interest and other income, net

     5,707      5,232      14,248      9,840
                           

Income before income taxes

     83,902      50,265      157,315      89,212

Provision for income taxes

     32,720      19,602      61,352      34,747
                           

Net lncome

   $ 51,182    $ 30,663    $ 95,963    $ 54,465
                           

Earnings per share:

           

Basic

   $ 1.32    $ 0.81    $ 2.48    $ 1.45
                           

Diluted

   $ 1.28    $ 0.79    $ 2.40    $ 1.41
                           

Shares used in computing earnings per share:

           

Basic

     38,773      37,636      38,677      37,463
                           

Diluted

     39,980      38,657      39,914      38,528
                           

 

* Includes stock compensation expense of $2.9 million and $1.5 million in total cost of revenue and $16.8 million and $7.8 million in total operating expenses for the three months ended June 30, 2008 and 2007, respectively; $5.2 million and $2.7 million in total cost of revenue and $29.1 million and $14.8 million in total operating expenses for the six months ended June 30, 2008 and 2007, respectively.


INTUITIVE SURGICAL, INC.

UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS

(IN THOUSANDS)

 

     6/30/2008    12/31/07

Cash, cash equivalents, and investments

   $ 739,782    $ 635,381

Accounts receivable, net

     162,088      130,370

Inventory

     42,594      32,416

Property and equipment, net

     94,568      68,093

Goodwill

     110,740      110,740

Deferred tax assets

     32,459      24,577

Other assets

     49,156      38,421
             

Total assets

   $ 1,231,387    $ 1,039,998
             

Accounts payable and other accrued liabilities

   $ 91,347    $ 96,632

Deferred revenue

     66,053      54,692
             

Total liabilities

     157,400      151,324

Stockholders’ equity

     1,073,987      888,674
             

Total liabilities and stockholders’ equity

   $ 1,231,387    $ 1,039,998